Antigen B from Echinococcus granulosus enters mammalian cells by endocytic pathways

PLoS Negl Trop Dis. 2018 May 4;12(5):e0006473. doi: 10.1371/journal.pntd.0006473. eCollection 2018 May.

Abstract

Background: Cystic hydatid disease is a zoonosis caused by the larval stage (hydatid) of Echinococcus granulosus (Cestoda, Taeniidae). The hydatid develops in the viscera of intermediate host as a unilocular structure filled by the hydatid fluid, which contains parasitic excretory/secretory products. The lipoprotein Antigen B (AgB) is the major component of E. granulosus metacestode hydatid fluid. Functionally, AgB has been implicated in immunomodulation and lipid transport. However, the mechanisms underlying AgB functions are not completely known.

Methodology/principal findings: In this study, we investigated AgB interactions with different mammalian cell types and the pathways involved in its internalization. AgB uptake was observed in four different cell lines, NIH-3T3, A549, J774 and RH. Inhibition of caveolae/raft-mediated endocytosis causes about 50 and 69% decrease in AgB internalization by RH and A549 cells, respectively. Interestingly, AgB colocalized with the raft endocytic marker, but also showed a partial colocalization with the clathrin endocytic marker. Finally, AgB colocalized with an endolysosomal tracker, providing evidence for a possible AgB destination after endocytosis.

Conclusions/significance: The results indicate that caveolae/raft-mediated endocytosis is the main route to AgB internalization, and that a clathrin-mediated entry may also occur at a lower frequency. A possible fate for AgB after endocytosis seems to be the endolysosomal system. Cellular internalization and further access to subcellular compartments could be a requirement for AgB functions as a lipid carrier and/or immunomodulatory molecule, contributing to create a more permissive microenvironment to metacestode development and survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Helminth / metabolism*
  • Cell Line
  • Echinococcosis / parasitology*
  • Echinococcosis / physiopathology
  • Echinococcus granulosus / genetics
  • Echinococcus granulosus / metabolism*
  • Endocytosis*
  • Helminth Proteins / metabolism*
  • Humans
  • Mice

Substances

  • Antigens, Helminth
  • Helminth Proteins

Grants and funding

This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (www.cnpq.br), grants 472316/2013-3 (AZ) and 470716/2014-2 (AZ), Fundação de Amparo à Pesquisa do Rio Grande do Sul (www.fapergs.rs.gov.br), grant 001892-25.51/13-0 (AZ), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (www.capes.gov.br), grant PARASITOLOGIA-1278/2011 (HBF). EDS is a recipient of a CNPq fellowship. MC is a recipient of a PNPD/CAPES postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.